EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN TREATMENT OF NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Kilickap, Saadettin [1 ]
机构：
[1] Hacettepe Univ, Kanser Enstitusu, Tibbi Onkol Bilim Dali, Ankara, Turkey
来源：
NOBEL MEDICUS | 2018年 / 14卷 / 03期
关键词：
Non-small cell lung cancer; EGFR; targeted therapy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Mutation of epidermal growth factor receptor (EGFR) is one of the targeted mutations in treatment of non-small cell lung cancer (NSCLC). Mutation of EGFR occurs in 15-40% of all patients with NSCLC. In this review, efficacy of different EGFR inhibitors used in NSCLC treatment is evaluated.
引用
收藏
页码：5 / 8
页数：4
相关论文
共 50 条
  • [11] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [12] Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3235 - 3242
  • [13] Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wildtype non-small cell lung cancer?
    Arriola, Edurne
    Taus, Alvaro
    Casadevall, David
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (04): : 45 - 56
  • [14] Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer
    Gao, Yuan
    Song, PingPing
    Li, Hui
    Guo, HongBo
    Jia, Hui
    Zhang, BaiJiang
    ONCOTARGETS AND THERAPY, 2016, 9 : 13 - 20
  • [15] Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer
    Bunn, PA
    Franklin, W
    SEMINARS IN ONCOLOGY, 2002, 29 (05) : 38 - 44
  • [16] Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    周清
    魏雪武
    高欣
    何韵婷
    杨潇蓉
    Science Foundation in China, 2019, 27 (01) : 72 - 80
  • [17] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer
    Ogunleye, Foluso
    Ibrahim, Mohammed
    Stender, Michael
    Kalemkerian, Gregory
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (01) : 16 - 25
  • [18] Epidermal growth factor receptor tyrosine kinase inhibitors - Application in non-small cell lung cancer
    Thomas, M
    CANCER NURSING, 2003, 26 (06) : 21S - 25S
  • [19] Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
    Hammerman, Peter S.
    Jaenne, Pasi A.
    Johnson, Bruce E.
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7502 - 7509
  • [20] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer
    Malik, Prabhat Singh
    Jain, Deepali
    Kumar, Lalit
    ONCOLOGY, 2016, 91 : 26 - 34
12345